Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy

Juan Zhou, Dong Wang, Ji-Hua Zheng, Zhu Wang, Bo Xie, Wei-Min Zhang

Open source

DOI
10.4103/0973-1482.165866
Published
2018
Container
Journal of Cancer Research and Therapeutics
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4103/0973-1482.165866,
  title = {Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy},
  author = {Juan Zhou and Dong Wang and Ji-Hua Zheng and Zhu Wang and Bo Xie and Wei-Min Zhang},
  year = {2018},
  journal = {Journal of Cancer Research and Therapeutics},
  doi = {10.4103/0973-1482.165866},
  url = {https://doi.org/10.4103/0973-1482.165866}
}

RIS

TY  - JOUR
TI  - Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy
AU  - Juan Zhou
AU  - Dong Wang
AU  - Ji-Hua Zheng
AU  - Zhu Wang
AU  - Bo Xie
AU  - Wei-Min Zhang
PY  - 2018
JO  - Journal of Cancer Research and Therapeutics
DO  - 10.4103/0973-1482.165866
UR  - https://doi.org/10.4103/0973-1482.165866
ER  - 

APA

Zhou, J., Wang, D., Zheng, J., Wang, Z., Xie, B., & Zhang, W. (2018). Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy. Journal of Cancer Research and Therapeutics. https://doi.org/10.4103/0973-1482.165866

Source records